Myeloma Survivor- Curative Intent and Secondary Cancers

The results of the current study support curative intent approaches to secondary cancers among patients with myeloma while highlighting the need for ongoing active myeloma management. FDA approved, standard-of-care

Continue reading

Can MGUS Patient Predict Progression to Multiple Myeloma?

“Individuals with low-risk/intermediate-risk MGUS can convert to high-risk MGUS and progress to multiple myeloma within five years…” I think it makes sense that serum immune markers of

Continue reading

Cytogenetic Prognostic Index in Multiple Myeloma

In all data sets, a higher PI (Cytogenetic Prognostic Index) was consistently associated with a poor survival outcome (for multiple myeloma patients) I wrote a blog post about once about key questions

Continue reading

Curcumin as Multiple Myeloma Therapy-Cytotoxic, Integrative and Selective

Curcumin (Cu) has been shown to inhibit the proliferation and survival of almost all types of tumor cells…” I am a long-term survivor of an incurable cancer called multiple myeloma (mm). I

Continue reading

6 Tips for Dealing with Cancer in the Early Stages

Finding out you have cancer for the first time can be a shock. As a result, you may go through a range of emotions when trying to come to terms with your new reality. However, after all of the emotions

Continue reading

Managing Chronic Atrial Fibrillation with Non-Conventional Therapy

One of the things I hear most often from my patients is, “I don’t want to take drugs. What are my alternatives? Are there any ways to treat atrial fibrillation with non-conventional therapy?” When

Continue reading

Deep Vein Thrombosis (Blood Clot) and Increased Risk of Cancer

“It is well known that early treatment is crucial for the prognosis of many types of cancer, and our findings show that an arterial thrombosis in the leg is associated with an increased risk of cancer

Continue reading

Health Insurance, Income, Hospital Influence Multiple Myeloma Outcome

“Having private insurance, living in a higher-income region and receiving treatment at an academic institution all appeared associated with significantly longer OS for patients with multiple myeloma…” Income,

Continue reading

“Hematopoietic stem cell transplantation, Cardiovascular Disease and Prevention-

“Hematopoietic stem cell transplantation recipients may be at an increased risk of developing hypertension, diabetes and dyslipidemia (referred to as cardiovascular risk factors (, p<0.01); the

Continue reading

Multiple Myeloma-“Your Brain after Chemo”

I began experiencing the symptoms of Post-chemotherapy cognitive impairment aka chemobrain in the years that followed my conventional therapies for multiple myeloma I was diagnosed with multiple myeloma

Continue reading